Published in Lancet Neurol on October 01, 2005
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis (2014) 4.64
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol (2011) 2.20
Neurocysticercosis: a review. ScientificWorldJournal (2012) 2.17
Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med (2016) 2.15
Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis (2011) 1.87
Hydrocephalus in neurocysticercosis. Childs Nerv Syst (2011) 1.70
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55
Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries. J Neurol Sci (2012) 1.42
Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis (2011) 1.31
The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet (2013) 1.29
Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology (2010) 1.27
Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev (2008) 1.27
Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS Negl Trop Dis (2009) 1.26
Advances in MRI for 'cryptogenic' epilepsies. Nat Rev Neurol (2011) 1.25
Corticosteroid use in neurocysticercosis. Expert Rev Neurother (2011) 1.17
Diagnostic criteria for neurocysticercosis, revisited. Pathog Glob Health (2012) 1.17
Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol (2010) 1.16
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. PLoS One (2013) 1.16
Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol (2010) 1.15
Cysticercosis of the central nervous system: how should it be managed? Curr Opin Infect Dis (2011) 1.09
Nested PCR for specific diagnosis of Taenia solium taeniasis. J Clin Microbiol (2007) 1.08
The incidence of human cysticercosis in a rural community of Eastern Zambia. PLoS Negl Trop Dis (2013) 1.07
Isolated intramedullary spinal cord cysticercosis. Asian J Neurosurg (2012) 1.05
Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg (2012) 1.04
Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa. PLoS Negl Trop Dis (2009) 1.03
Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States. Emerg Infect Dis (2012) 1.03
Neglected parasitic infections in the United States: cysticercosis. Am J Trop Med Hyg (2014) 1.01
Neurocysticercosis in the United States. Pathog Glob Health (2012) 0.98
A transcriptomic analysis of Echinococcus granulosus larval stages: implications for parasite biology and host adaptation. PLoS Negl Trop Dis (2012) 0.98
Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts. Antimicrob Agents Chemother (2010) 0.97
Monitoring the outcomes of interventions against Taenia solium: options and suggestions. Parasite Immunol (2016) 0.94
Ocular pentastomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis (2014) 0.93
A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases. PLoS Negl Trop Dis (2012) 0.91
High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology (2012) 0.90
Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. Indian J Med Res (2011) 0.90
Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health (2012) 0.89
A rare case of racemose neurocysticercosis and its complications. Case report. Neuroradiol J (2015) 0.88
Evaluating the efficacy of teaching methods regarding prevention of human epilepsy caused by Taenia solium neurocysticercosis in Western Kenya. Am J Trop Med Hyg (2010) 0.87
Neurologic parasitic infections in immigrants and travelers. Semin Neurol (2011) 0.87
Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment. Exp Parasitol (2013) 0.86
Neurocysticercosis. Neurohospitalist (2014) 0.86
Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol (2006) 0.86
Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccine. Vet Parasitol (2012) 0.86
Midbrain cysticercal cyst. J Neurosci Rural Pract (2012) 0.86
A clinical, radiological and outcome study of status epilepticus from India. J Neurol (2010) 0.86
Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review. J Clin Neurol (2015) 0.85
Neurocysticercosis on the Arabian Peninsula, 2003-2011. Emerg Infect Dis (2013) 0.85
MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis. Infect Immun (2009) 0.84
Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis (2013) 0.84
Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity. Am J Pathol (2009) 0.83
Analyses of an expressed sequence tag library from Taenia solium, Cysticerca. PLoS Negl Trop Dis (2010) 0.83
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin Microbiol Rev (2014) 0.83
Factors associated with the prevalence of circulating antigens to porcine cysticercosis in three villages of burkina faso. PLoS Negl Trop Dis (2011) 0.82
Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis. Infect Immun (2013) 0.82
Characterization of a novel Taenia solium oncosphere antigen. Mol Biochem Parasitol (2007) 0.82
Taeniasis among Refugees Living on Thailand-Myanmar Border, 2012. Emerg Infect Dis (2015) 0.82
Novel rat model for neurocysticercosis using Taenia solium. Am J Pathol (2015) 0.81
Helminth induced suppression of macrophage activation is correlated with inhibition of calcium channel activity. PLoS One (2014) 0.81
Progesterone induces mucosal immunity in a rodent model of human taeniosis by Taenia solium. Int J Biol Sci (2011) 0.81
Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia (2014) 0.81
Neurocysticercosis in immigrant populations. J Travel Med (2012) 0.81
Tamoxifen treatment in hamsters induces protection during taeniosis by Taenia solium. Biomed Res Int (2012) 0.80
Changes in gene expression of pial vessels of the blood brain barrier during murine neurocysticercosis. PLoS Negl Trop Dis (2013) 0.80
Neurocysticercosis in a 2-year-old boy infected at home. Pathog Glob Health (2012) 0.80
Current status and future perspectives on the medical treatment of neurocysticercosis. Pathog Glob Health (2012) 0.80
Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLoS Negl Trop Dis (2012) 0.80
Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis. PLoS Negl Trop Dis (2015) 0.80
Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis. Clin Infect Dis (2016) 0.80
Intradural Neurocysticercosis of Lumbar Spine: A Case Report. Global Spine J (2014) 0.79
Managing neurocysticercosis: challenges and solutions. Int J Gen Med (2015) 0.79
The present situation and towards the prevention and control of neurocysticercosis on the tropical island, Bali, Indonesia. Parasit Vectors (2015) 0.79
Progesterone induces scolex evagination of the human parasite Taenia solium: evolutionary implications to the host-parasite relationship. J Biomed Biotechnol (2009) 0.79
Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. J Immunol (2010) 0.78
Transcriptome analysis of the ependymal barrier during murine neurocysticercosis. J Neuroinflammation (2012) 0.78
Immunodiagnosis of neurocysticercosis: ways to focus on the challenge. J Biomed Biotechnol (2011) 0.78
Neurocysticercosis: A disease of neglect. Trop Parasitol (2013) 0.78
An uncommon cause of seizures in children living in developed countries: neurocysticercosis--a case report. Ital J Pediatr (2011) 0.78
Transient cortical blindness as a manifestation of solitary cysticercus granuloma. BMJ Case Rep (2012) 0.78
Neurocysticercotic Calcifications and Hippocampal Sclerosis: A Case-Control Study. PLoS One (2015) 0.77
Neurocysticercosis: declining incidence among patients admitted to a large public hospital in Guayaquil, Ecuador. Pathog Glob Health (2012) 0.77
Differentiating Taenia eggs found in human stools: does Ziehl-Neelsen staining help? Trop Med Int Health (2010) 0.77
Neurocysticercosis with a single brain lesion in Germany: a case report. Cases J (2009) 0.77
Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells. Planta (2015) 0.77
Reduced Leukocyte Infiltration in Absence of Eosinophils Correlates with Decreased Tissue Damage and Disease Susceptibility in ΔdblGATA Mice during Murine Neurocysticercosis. PLoS Negl Trop Dis (2016) 0.76
Proteomic survey of the cestode Mesocestoides corti during the first 24 hours of strobilar development. Parasitol Res (2010) 0.76
Genes encoding homologous antigens in taeniid cestode parasites: Implications for development of recombinant vaccines produced in Escherichia coli. Bioengineered (2012) 0.75
Seizures, cysticercosis and rural-to-urban migration: the PERU MIGRANT study. Trop Med Int Health (2015) 0.75
Disseminated cysticercosis with a right common femoral vein thrombosis. BMJ Case Rep (2013) 0.75
Third-ventricular neurocysticercosis: hydraulic maneuvers facilitating endoscopic resection. Childs Nerv Syst (2013) 0.75
Platelet function parameters in management of hepatic hydatid disease: a case-controlled study. Int J Clin Exp Med (2015) 0.75
Commentary. J Neurosci Rural Pract (2012) 0.75
Commentary. J Neurosci Rural Pract (2013) 0.75
A new parasiticidal compound in T. solium cysticercosis. Biomed Res Int (2012) 0.75
Human cysticercosis (Taenia solium). Trop Parasitol (2013) 0.75
Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review. Transpl Infect Dis (2015) 0.75
Hemorrhagic cerebrovascular events and neurocysticercosis: a case report and review of the literature. Am J Trop Med Hyg (2011) 0.75
Use of suction to treat intramedullary spinal cysticercosis. BMJ Case Rep (2010) 0.75
Taenia solium cysticercosis. Lancet (2003) 5.89
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis (2014) 4.64
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Imaging findings in neurocysticercosis. Acta Trop (2003) 3.19
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med (2016) 2.15
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke (2003) 1.85
Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Assist Tomogr (2005) 1.67
Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55
Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54
Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg (2001) 1.52
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47
Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology (2010) 1.27
Stroke following Bothrops spp. snakebite. Neurology (2003) 1.25
Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains. Am J Trop Med Hyg (2001) 1.23
Combined human and porcine mass chemotherapy for the control of T. solium. Am J Trop Med Hyg (2006) 1.17
Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg (2001) 1.17
Review of neurocysticercosis. Neurosurg Focus (2002) 1.16
Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci (2007) 1.14
Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am J Trop Med Hyg (2005) 1.13
Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol (2011) 1.13
Nested PCR for specific diagnosis of Taenia solium taeniasis. J Clin Microbiol (2007) 1.08
Protection of pigs with cysticercosis from further infections after treatment with oxfendazole. Am J Trop Med Hyg (2001) 1.06
Epilepsy and neurocysticercosis: an incidence study in a Peruvian rural population. Neuroepidemiology (2009) 1.04
Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg (2012) 1.04
Absence of brain involvement and factors related to positive serology in a prospective series of 61 cases with pulmonary hydatid disease. Am J Trop Med Hyg (2008) 1.04
Relationship between serum antibodies and Taenia solium larvae burden in pigs raised in field conditions. PLoS Negl Trop Dis (2013) 0.98
C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Stroke (2014) 0.97
Taenia solium oncosphere adhesion to intestinal epithelial and Chinese hamster ovary cells in vitro. Infect Immun (2007) 0.97
Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis. Am J Trop Med Hyg (2003) 0.96
Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg (2002) 0.96
Neurocysticercosis in nonendemic countries: time for a reappraisal. Neuroepidemiology (2012) 0.95
Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs. PLoS Negl Trop Dis (2012) 0.94
Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol (2012) 0.93
Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl Trop Dis (2014) 0.92
Detection of muscle calcifications by thigh CT scan in neurocysticercosis patients. Trans R Soc Trop Med Hyg (2005) 0.91
Seroincidence of porcine T. solium infection in the Peruvian highlands. Prev Vet Med (2003) 0.91
Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clin Neurol Neurosurg (2001) 0.91
High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology (2012) 0.90
Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health (2012) 0.89
Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health (2012) 0.89
Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst. Clin Neurol Neurosurg (2005) 0.89
Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions. Trans R Soc Trop Med Hyg (2006) 0.88
Evans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia solium. PLoS One (2014) 0.86
Validity of the Enzyme-linked Immunoelectrotransfer Blot (EITB) for naturally acquired porcine cysticercosis. Vet Parasitol (2013) 0.85
Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens (2013) 0.85
Neurocysticercosis on the Arabian Peninsula, 2003-2011. Emerg Infect Dis (2013) 0.85
Ring-screening to control endemic transmission of Taenia solium. PLoS Negl Trop Dis (2014) 0.84
Short report: secondary transmission in porcine cysticercosis: description and their potential implications for control sustainability. Am J Trop Med Hyg (2005) 0.84
Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis (2013) 0.84
Scorpion stings: focus on cerebrovascular complications of envenoming. Int J Stroke (2013) 0.83
Post-treatment vascular leakage and inflammatory responses around brain cysts in porcine neurocysticercosis. PLoS Negl Trop Dis (2015) 0.83
Immunology of Taenia solium taeniasis and human cysticercosis. Parasite Immunol (2014) 0.83
Identification and Characterization of Microsatellite Markers Derived from the Whole Genome Analysis of Taenia solium. PLoS Negl Trop Dis (2015) 0.82
Characterization of a novel Taenia solium oncosphere antigen. Mol Biochem Parasitol (2007) 0.82
Proteomic study of activated Taenia solium oncospheres. Mol Biochem Parasitol (2010) 0.82
Neurocysticercosis in immigrant populations. J Travel Med (2012) 0.81
Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia (2014) 0.81
Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med (2007) 0.81
Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis. Clin Infect Dis (2016) 0.80
Diphyllobothrium pacificum infection is seldom associated with megaloblastic anemia. Am J Trop Med Hyg (2012) 0.80
Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis. PLoS Negl Trop Dis (2015) 0.80
Changing profile of 7,519 neurologic outpatients evaluated over 20 years. Eur Neurol (2012) 0.80
Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer. PLoS Negl Trop Dis (2014) 0.79
Technical difficulties due to poor acoustic insonation during transcranial Doppler recordings in Amerindians and individuals of European origin. A comparative study. Eur Neurol (2015) 0.79
Characteristics of 478 very old neurologic outpatients evaluated over 20 years in Guayaquil, Ecuador. Acta Neurol Belg (2012) 0.79
Taenia solium infection in Peru: a collaboration between Peace Corps Volunteers and researchers in a community based study. PLoS One (2014) 0.78
Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model. Am J Trop Med Hyg (2015) 0.77
Neurocysticercosis and the global world. J Neurol (2002) 0.77
Pathogenesis of Taenia solium taeniasis and cysticercosis. Parasite Immunol (2016) 0.77
GPS Tracking of Free-Ranging Pigs to Evaluate Ring Strategies for the Control of Cysticercosis/Taeniasis in Peru. PLoS Negl Trop Dis (2016) 0.77
Differentiating Taenia eggs found in human stools: does Ziehl-Neelsen staining help? Trop Med Int Health (2010) 0.77
Neurocysticercosis: declining incidence among patients admitted to a large public hospital in Guayaquil, Ecuador. Pathog Glob Health (2012) 0.77
Neurocysticercosis in Australia: still free of autochthonous cases? Med J Aust (2012) 0.77
Human hydatid disease in Peru is basically restricted to Echinococcus granulosus genotype G1. Am J Trop Med Hyg (2008) 0.76
Perilesional Inflammation in Neurocysticercosis - Relationship Between Contrast-Enhanced Magnetic Resonance Imaging, Evans Blue Staining and Histopathology in the Pig Model. PLoS Negl Trop Dis (2016) 0.76
A novel Taenia solium protein that resembles troponin T proteins. J Parasitol (2009) 0.76
Taenia solium infection in a rural community in the Peruvian Andes. Ann Trop Med Parasitol (2003) 0.76
Anti-Taenia solium monoclonal antibodies for the detection of parasite antigens in body fluids from patients with neurocysticercosis. Exp Parasitol (2016) 0.75
In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium. Antimicrob Agents Chemother (2012) 0.75
Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. PLoS Negl Trop Dis (2017) 0.75
High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru. PLoS Negl Trop Dis (2016) 0.75
Reversible posterior leukoencephalopathy in a venomous snake (Bothrops asper) bite victim. Am J Trop Med Hyg (2012) 0.75
Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies. Int J Toxicol (2015) 0.75
The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs. Vet Immunol Immunopathol (2011) 0.75
Case 15-2012: Diplopia, headaches, and papilledema. N Engl J Med (2012) 0.75
In Vitro Study of Taenia solium Postoncospheral Form. PLoS Negl Trop Dis (2016) 0.75
Seizures, cysticercosis and rural-to-urban migration: the PERU MIGRANT study. Trop Med Int Health (2015) 0.75
Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep. Am J Trop Med Hyg (2012) 0.75
Movement Disorders Among Adult Neurological Outpatients Evaluated over 20 Years in Guayaquil, Ecuador. Neurol Int (2013) 0.75
Psychological distress in patients with restless legs syndrome (Willis-Ekbom disease): a population-based door-to-door survey in rural Ecuador. BMC Res Notes (2014) 0.75
Infection and inflammation. Handb Clin Neurol (2012) 0.75